Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plurair vs Flixonase in Perennial Allergic Rhinitis
NCT04332978Phase 3Completed
- Sponsor
- Libbs Farmacêutica
- Start
- Jul 2014
- Primary completion
- Apr 2020
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of fluticasone propionate in perennial allergic rhinitis (PAR), sponsored by Libbs Farmacêutica. Started Jul 2014; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT04332978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04332978.